Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
-350K
-
Total reported value, excl. options
-
$383M
-
Value change
-
-$53.6M
-
Put/Call ratio
-
4.03
-
Number of buys
-
60
-
Number of sells
-
-36
-
Price
-
$12.29
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2016
118 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2016.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
of 170M outstanding shares and own 18.29% of the company stock.
Largest 10 shareholders include Flagship Ventures Management, Inc. (12.7M shares), FMR LLC (6.04M shares), FEDERATED INVESTORS INC /PA/ (2.04M shares), VANGUARD GROUP INC (1.35M shares), Capital World Investors (1.34M shares), BlackRock Fund Advisors (994K shares), PRICE T ROWE ASSOCIATES INC /MD/ (753K shares), D. E. Shaw & Co., Inc. (525K shares), Artal Group S.A. (500K shares), and BlackRock Institutional Trust Company, N.A. (427K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.